bpc-157/thymosin beta 4 - 3mg/3mg/ ml for sale Thymosin BPC-157 / Thymosin Beta-4 -
Description
This formulation is indicated for the treatment of cobalamin deficiency states, including pernicious anemia, and for the treatment of cyanide poisoning
10.1371/journal.pone.0025637 177
Pregnancy and breastfeeding would be obvious contraindications given the lack of safety data
[5] However, because it is not FDA-approved for therapeutic use in the United States, its administration is considered off-label or investigational, making medical supervision essential rather than optional
